n-(3-(aminomethyl)benzyl)acetamidine has been researched along with Breast Cancer in 2 studies
N-(3-(aminomethyl)benzyl)acetamidine: structure in first source
N-[3-(aminomethyl)benzyl]acetamidine : An aralkylamine that is Nbenzylacetamidine substituted at position 3 on the benzene ring by an aminomethyl group. An inhibitor of nitric oxide synthase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Orthotopic murine breast tumors (4T1 and E0771 with high and low MMP14 expression, respectively; n = 5-10 per group) were treated with an anti-MMP14 inhibitory antibody (DX-2400), IgG control, fractionated radiation therapy, or their combination." | 1.42 | Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy. ( Ager, EI; Askoxylakis, V; Boucher, Y; Devy, L; Dransfield, DT; Finkelstein, DM; Fukumura, D; Goel, S; Huang, Y; Jain, RK; Kirkpatrick, ND; Kodack, DP; Kozin, SV; Muzikansky, A; Seano, G; Snuderl, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ager, EI | 1 |
| Kozin, SV | 1 |
| Kirkpatrick, ND | 1 |
| Seano, G | 1 |
| Kodack, DP | 1 |
| Askoxylakis, V | 1 |
| Huang, Y | 1 |
| Goel, S | 1 |
| Snuderl, M | 1 |
| Muzikansky, A | 1 |
| Finkelstein, DM | 1 |
| Dransfield, DT | 1 |
| Devy, L | 1 |
| Boucher, Y | 1 |
| Fukumura, D | 1 |
| Jain, RK | 1 |
| Fahey, JM | 1 |
| Girotti, AW | 1 |
2 other studies available for n-(3-(aminomethyl)benzyl)acetamidine and Breast Cancer
| Article | Year |
|---|---|
Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.
Topics: Amidines; Animals; Antibodies, Monoclonal; Antineoplastic Agents; Benzylamines; Breast Neoplasms; Ce | 2015 |
Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
Topics: Amidines; Aminolevulinic Acid; Animals; Apoptosis; Apoptosis Regulatory Proteins; Benzoates; Benzyla | 2017 |